You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-GSK3 alpha (phospho S21) antibody (ab9765)

Overview

Properties

Applications

Our Abpromise guarantee covers the use of ab9765 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB
  • Application notesWestern blot: use at 1/1000.
    This product has been assayed by ELISA against 0.1µg of the immunizing peptide.
    A 1/1000 to 1/5000 dilution of the antibody is recommended for this assay.
    Not tested in other applications.

    Optimal dilutions / concentrations should be determined by the end user.
  • Target

    • Alternative names
        DKFZp686D0638 antibodyGlycogen synthase kinase 3 alpha antibodyGlycogen synthase kinase-3 alpha antibody
        GSK 3 alpha antibodyGSK 3 alpha antibodyGSK 3A antibodyGSK-3 alpha antibodyGSK3A antibodyGSK3A_HUMAN antibodyGSK3alpha antibodySerine/threonine protein kinase GSK3A antibody
      see all

    Anti-GSK3 alpha (phospho S21) antibody images

    • Rabbit polyclonal to phospho GSK alpha (Ser 21) at 1/1000 on 293T cell extract shows a band at 52 kD.
      Cells were serum starved for 24 hours:

      Lane 1 : control
      Lane 2 : treated with IGF-1 (100 ng/ml) for 20 min
      Lane 3 : pre-treated with 10 uM LY294002 (selective PI3K inhibitor) and treated with IGF-1 (100 ng/ml) for 20 min

      Angela Carter, Experimental Therapeutics, Ontario Cancer Inst, Toronto, Canada

    References for Anti-GSK3 alpha (phospho S21) antibody (ab9765)

    ab9765 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab9765.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"